Medicare utilization — DR. MELISSA ANNE RUBENSTEIN (MD)

← Back to profile

Calendar year 2023 · data refreshed 2026-05-27

HCPCSDescriptionServicesBeneficiariesAllowedPayment
17003Destruction of precancer skin growth, 2-14 growths1,203221$0$6,035
99213Established patient office or other outpatient visit, 20-29 minutes594374$0$36,878
17000Destruction of precancer skin growth, 1 growth452295$0$17,350
11102Biopsy of related skin growth, first growth342257$0$24,718
11103Biopsy of related skin growth, each additional growth224118$0$8,955

Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.

Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·